Subscribe
There’s a new way to lower LDL cholesterol levels-by approximately 60% to 80%. Studies unveiled at the 2012 ACC meeting found that an injectable monoclonal antibody, when added to statin therapy cuts LDL cholesterol levels far in excess of what can be achieved with statin therapy alone. Drs Christopher Cannon and Payal Kohli discuss.
Statin Therapy and Oral Antidiabetic Drugs: On Adherence and Initiation
Sugary Drinks and Coronary Heart Disease
Women and Heart Disease-Questions and Answers for the Primary Care Physician
Statins and the New FDA Warnings: What Does It All Mean for Your Patients?
Jessica Ailani, MD, FAHS, FAAN; Paul G. Mathew, MD, DNBPAS, FAAN, FAHS
Asim V. Farooq, MD; Joann Kang, MD; Nita Lee, MD, MPH
Sanjai Rao, MD, DFAPA; Dawn I. Velligan, PhD
Jacob Sands, MD; Beth Sandy, MSN, CRNP, FAPO; Stephanie McDonald, FNP-BC, AOCNP
John F. Brandsema, MD; Abigail N. Schwaede, MD; Samuel J. Mackenzie, MD, PhD
Anil K. Agarwal, MD; Nissreen Elfadawy, MD, MSc, FASN
Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD
Eytan M. Stein, MD; Marina Kremyanskaya, MD, PhD; Hannah Levavi, MD
Deborah Ristvedt, DO; Melissa Tawa, OD, FAAO
Daniel J. DeAngelo, MD, PhD; Claire Roddie, MD, PhD
Rami Komrokji, MD; Maen Hussein, MD